Lesina was previously at Lonza as Executive Director and will be responsible for implementing a strategy that targets small and medium brands launching new nutraceutical formulations.
Sirio Pharma (Pritzwalk, Germany) has appointed Sara Lesina as General Manager in Europe. Lesina was previously at Lonza as Executive Director and will be responsible for implementing a strategy that targets small and medium brands launching new nutraceutical formulations.
“I joined Sirio because I see the tremendous resources it has – over 200 R&D scientists at its sites – and there are clear synergies with like-minded, innovation-driven customers,” said Lesina. in a press release. “We anticipate significant growth in the nutra market over the next few years as customers see the benefits of working with an agile CDMO partner to help bring products to market faster. Sirio’s value proposition anchored on R&D and formulation capabilities, combined with our global manufacturing footprint, positions us well to capitalize on this growth by launching new products for customers.
Rui Yang, Vice President of Sirio Pharma, said in a press release, “Sara brings with her a tremendous global network and what impressed us was the clarity of purpose in establishing Sirio as a contract research and development center for the world’s most ambitious brands. Across Europe, an increasing number of companies are launching new products that could reduce their time to market and/or acquisition by working with Sirio. Sara’s mission will be to help develop locally relevant formulation options, serving as a European conduit to access Sirio’s global R&D resources.
